Jack Ball - Nov 14, 2022 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Role
Director
Signature
/s/ Valerie Barnett, Attorney-in-Fact for Jack Ball
Stock symbol
CTKB
Transactions as of
Nov 14, 2022
Transactions value $
-$228,640
Form type
4
Date filed
11/16/2022, 04:53 PM
Previous filing
Jun 3, 2022
Next filing
Nov 30, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTKB Common Stock Options Exercise $6.4K +16K +533.33% $0.40* 19K Nov 14, 2022 Direct
transaction CTKB Common Stock Sale -$235K -16K -84.21% $14.69 3K Nov 14, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTKB Stock Option (Right to Buy) Options Exercise $0 -16K -60% $0.00 10.7K Nov 14, 2022 Common Stock 16K $0.40 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.53 to $14.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.